National Kidney Foundation Announces the Launch of Kidney Medicine

 

 

New York, NY, Oct. 23, 2018 - The National Kidney Foundation (NKF), and Elsevier, the information analytics business specializing in science and health, announced today the launch of Kidney Medicine, a peer-reviewed, open access journal focused on clinical research in nephrology and hypertension.

 

Led by Editor-in-Chief Daniel E. Weiner, MD, MS, and an editorial board of experts in the field, Kidney Medicine is designed to rapidly disseminate knowledge relevant to the care of people with or at risk of kidney diseases. The journal will publish original research, case reports, and review articles spanning a wide range of topics, including qualitative and quantitative research; health care policy, delivery and disparities research; and epidemiology and outcomes research. Kidney Medicine also seeks research on assessing and improving nephrology education and patient-reported outcomes.

 

“As an official journal of the National Kidney Foundation, we are excited to take on the challenge of meeting the high standards of other NKF journals, like American Journal of Kidney Diseases (AJKD), Advances in CKD, and the Journal of Renal Nutrition,” Dr. Weiner said. “In serving as Deputy Editor at AJKD for 10 years, I saw so many excellent articles that we could not publish. I see Kidney Medicine as filling a need in the kidney space, providing a gold open access journal with content that encompasses all clinical nephrology while additionally providing a platform for highlighting the patient-reported outcomes research and qualitative research that are essential for improving patient care.”

 

AJKD’s Editor-in-Chief, Harold I. Feldman, MD, MSCE, FACE sees the new journal as a complement to NKF’s flagship journal.

 

”AJKD is very pleased to welcome Kidney Medicine as a sister journal, providing authors seeking to publish in a fully open access journal with a home for their work within the NKF publishing portfolio,” Dr. Feldman said. “Weiner's editorial experience and his energy and engagement with the nephrology community make him an ideal inaugural Editor-in-Chief of Kidney Medicine and we look forward to the launch of this important new publication.”

 

Kidney Medicine is currently accepting submissions and will publish its first issue in early 2019. The journal promises fast and fair decisions while maintaining a rigorous peer review process. Authors publishing in Kidney Medicine will benefit from a quality review process, quick turn-around times, and open access publication of their papers on ScienceDirect.

           

“By providing timely and open access to quality research in kidney disease, the NKF is confident that Kidney Medicine will improve the care and health outcomes of the patients we serve,” said Kerry Willis, PhD, NKF’s Chief Scientific Officer.

 

For information or to submit an article, visit Kidney Medicine.

 

Elsevier is a global information analytics business that helps institutions and professionals advance healthcare, open science and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support and professional education, including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 38,000 e-book titles and many iconic reference works, including Gray’s Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries.

 

Healthcare professionals can join NKF to receive access to tools and resources for both patients and professionals, subscriptions to professional journals, discounts on professional education, and access to a network of thousands of individuals who treat patients with kidney disease. 

 

Thirty million American adults are estimated to have chronic kidney disease — and most aren’t aware of it. One in 3 American adults are at risk for chronic kidney disease. Risk factors for kidney disease include diabetes, high blood pressure, heart disease, obesity and family history of kidney failure. People of African American, Hispanic, Native American, Asian or Pacific Islander descent are at increased risk for developing the disease. African Americans are three times more likely than Whites, and Hispanics are nearly 1.5 times more likely than non-Hispanics to develop end-stage renal disease (kidney failure).